Contents:

Analgesics in Denmark Euromonitor International October 2009 List of Contents and Tables Executive Summary Strong Market Performance in 2008 Convenience Is A Key Growth Driver Leading Multinationals and Vitamin and Dietary Supplement Manufacturers Performed Best Pharmacies and Drugstores Lost Share Strong Growth To Continue During Forecast Period Key Trends and Developments Liberalisation Process Slows Down Consolidation Strategies Begin To Bear Fruit Trend Towards Generics and Parallel Imports Continues Convenience Is A Key Consumer Trend Long-term Decline in Public Health Is A Key Demand Driver Boom in Internet Sales Continues Market Indicators Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008 Table 2 Life Expectancy at Birth 2003-2008 Market Data Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008 Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008 Table 5 OTC Healthcare Company Shares by Value 2004-2008 Table 6 OTC Healthcare Brand Shares by Value 2005-2008 Table 7 Penetration of Private Label by Sector 2003-2008 Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008 Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008 Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013 Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013 Appendix OTC Registration and Classification Vitamins & Dietary Supplements Registration and Classification EU Legislation European Regulatory Systems Marketing Authorisations Distribution Pricing Switch Climate Centralised Procedure Regulation of Vitamins and Dietary Supplements Regulation of Herbal Products Self-medication and Preventative Medicine Generics Switches Summary 1 OTC Healthcare Switches 2005-2007 Definitions Summary 2 Research Sources Actavis A/S Strategic Direction Key Facts Summary 3 Actavis Nordic A/S: Key Facts Company Background Production Competitive Positioning Summary 4 Actavis Nordic A/S: Competitive Position 2008 Cederroth A/S Strategic Direction Key Facts Summary 5 Cederroth A/S: Key Facts Company Background Production Competitive Positioning Summary 6 Cederroth A/S: Competitive Position 2008 Ferrosan A/S Strategic Direction Key Facts Summary 7 Ferrosan A/S: Key Facts Summary 8 Ferrosan A/S: Operational Indicators Company Background Competitive Positioning Summary 9 Ferrosan A/S: Competitive Position 2008 Nycomed Danmark A/S Strategic Direction Key Facts Summary 10 Nycomed Danmark A/S: Key Facts Summary 11 Nycomed Group: Operational Indicators Company Background Production Competitive Positioning Summary 12 Nycomed Danmark A/S: Competitive Position 2008 Orifarm A/S Strategic Direction Key Facts Summary 13 Orifarm A/S: Key Facts Summary 14 Orifarm Group: Operational Indicators Company Background Production Competitive Positioning Summary 15 Orifarm A/S: Competitive Position 2008 Headlines Trends Competitive Landscape Prospects Sector Data Table 12 Sales of Analgesics by Subsector: Value 2003-2008 Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008 Table 14 Herbal vs Standard Topical Analgesics 2003-2008 Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2008 Table 16 Analgesics Company Shares by Value 2004-2008 Table 17 Analgesics Brand Shares by Value 2005-2008 Table 18 Forecast Sales of Analgesics by Subsector: Value 2008-2013 Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013